This site is intended for US healthcare professionals only

What is Optune Lua?

Patients remain at the heart of the work we do every day, including our innovations in the Optune Lua device for patients living with MPM

Original Optune® system

Second-generation Optune Lua system

Designed for more convenience, carrying comfort and usability—the second-generation Optune Lua system is2:

More compact

  • Smaller-profile carrying case with easy-grip texture

More convenient

  • 5 different ways to carry the device

Equipped with smart technology

  • Battery indicator alerts patients to change battery and light sensor auto-dims for night use

Loco-regional delivery of Tumor Treating Fields (TTFields) via transducer arrays provides antimitotic activity directly at the site of the malignancy1

Actor portrayal 

  • TTFields are added to pemetrexed + cisplatin or carboplatin systemic therapies
  • The size and placement of transducer arrays are customized based on gender, body type, and tumor location
    • Novocure® will provide a customized map for array placement based on patient-specific measurements and tumor location (determined via CT scans).
  • It is recommended that Optune Lua is turned on at least 75% of the time (18 hours per day)
    • Patients have the flexibility to decide which times of the day are best for them, including at night when sleeping
Next: Mechanism of Action

MPM, malignant pleural mesothelioma.

 

References: 1. Optune Lua. Instructions for Use for Unresectable Malignant Pleural Mesothelioma. Novocure; 2021. 2. Optune Lua. Patient Information and Operation Manual for Unresectable Malignant Pleural Mesothelioma. Novocure; 2021.

Caution: Federal law restricts this device to sale by or on the order of a physician. Humanitarian Device. Authorized by Federal Law for use in the treatment of adult patients with unresectable, locally advanced or metastatic, malignant pleural mesothelioma concurrently with pemetrexed and platinum-based chemotherapy. The effectiveness of this device for this use has not been demonstrated.

 

Indication For Use

Optune Lua® is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic, malignant pleural mesothelioma (MPM) to be used concurrently with pemetrexed and platinum-based chemotherapy.

 

Important Safety Information 

Contraindications

Do not use Optune Lua in patients with implantable electronic medical devices such as pacemakers or implantable automatic defibrillators, etc. Use of Optune Lua together with implanted electronic devices has not been tested and may lead to malfunctioning of the implanted device.

 

Do not use Optune Lua in patients known to be sensitive to conductive hydrogels. Skin contact with the gel used with Optune Lua may commonly cause increased redness and itching, and may rarely lead to severe allergic reactions such as shock and respiratory failure.

 

Warnings and Precautions

Optune Lua can only be prescribed by a healthcare provider that has completed the required certification training provided by Novocure®.

 

The most common (≥10%) adverse events involving Optune Lua in combination with chemotherapy were anemia, constipation, nausea, asthenia, chest pain, fatigue, medical device site reaction, pruritus, and cough.

 

Other potential adverse effects associated with the use of Optune Lua include: treatment related skin toxicity, allergic reaction to the plaster or to the gel, electrode overheating leading to pain and/or local skin burns, infections at sites of electrode contact with the skin, local warmth and tingling sensation beneath the electrodes, muscle twitching, medical device site reaction and skin breakdown/skin ulcer.

 

If the patient has an underlying serious skin condition on the chest, evaluate whether this may prevent or temporarily interfere with Optune Lua treatment.

 

Do not prescribe Optune Lua for patients that are pregnant, you think might be pregnant or are trying to get pregnant, as the safety and effectiveness of Optune Lua in these populations have not been established.

 

Please click here to see Optune Lua Instructions For Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

Novocure Websites

This website is intended for people seeking information on Optune Lua.

 

On this site, videos and images identified as Optune Lua users, care partners, or healthcare professionals depict actual patients, care partners, and healthcare professionals.

 

Patient images reflect the health status of the patients at the time each photo or video was taken.


External links

Tumortreatingfieldstherapy.com
Optunegio.com
Optunelua.com
Novocure.com
Novocuretrials.com


©2024 Novocure GmbH. All Rights Reserved.

MyNovocure, Novocure, and Optune Lua are registered trademarks of Novocure GmbH.

US-OPL-00037 v1.0 October 2024